एसेल आरो गेजेर जखानि गिनो गोनां बेरामिफोरा केम’टेरापि बादि मुलि जेरै-मेट’ट्रेसाइट रो 6 मेरकेपट’पिउरिन बाहायनो हायो।
Patients with low- to average-risk ALL receive therapy with antimetabolite drugs such as methotrexate and 6-mercaptopurine (6-MP).